Thousands more breast cancer patients to benefit from new NHS treatment
NICE approves ribociclib combination therapy to help prevent cancer returning in early-stage disease.
News, blogs and podcasts
Latest articles
Four AI technologies conditionally recommended to help detect undiagnosed fragility fractures
The technologies could help healthcare professionals spot hidden spinal fractures in patients undergoing routine CT scans.
New cystic fibrosis drug fast-tracked for NHS use
Some people with cystic fibrosis are set to benefit from a new once-daily triple therapy treatment, following NICE's recommendation of Alyftrek in final draft guidance published today.
NICE provisionally recommends leadless implantable pacemaker in draft guidance
A procedure for people with slow heart rhythms could be used more widely after it was recommended for NHS use in draft guidance.
Latest in-depth
NICE annual report and accounts 2024/25
Our annual report and accounts, which summarises our key achievements from April 2024 to March 2025.
Strengthening Egypt's healthcare system through technology assessment
NICE International has helped Egypt take a crucial step towards a fairer, more efficient healthcare system.
Latest blogs
NICE responds to publication of the government’s Life Sciences Sector Plan
We welcome the publication of the government's Life Sciences Sector Plan, which sets out how NICE will ensure patients get faster, fairer access to transformative new medicines and life-changing healthtech, while supporting a thriving life sciences industry in the UK.
NHS 10 Year Health Plan empowers NICE to get patients better care, faster
Dr Sam Roberts, NICE's chief executive, welcomes the government's 10 Year Health Plan, which marks a pivotal moment for healthcare and strengthens NICE’s role.
Latest podcasts
NICE's prioritisation board: focus on what matters most
Learn more about our updated maternal and child nutrition guideline
